COMORBIDITY IN PATIENTS WITH OBESITY III IN DYNAMICS OF WEIGHT LOSS AFTER INTRAGASTRIC BALLOON INSTALLATION AND LAPAROSCOPIC SLEEVE GASTRECTOMY
DOI:
https://doi.org/10.11603/2415-8798.2018.3.9203Keywords:
comorbidity, obesity, weight loss, intragastric balloon, laparoscopic sleeve gastrectomyAbstract
The cost of medical care for obese people is much higher than for people with normal weight.
The aim of the study – to evaluate the comorbidity in patients with obesity III in dynamics of weight loss after laparoscopic sleeve gastrectomy (LSG) and intragastric balloon installation (IBI).
Materials and Methods. 20 patients, 19–55 years old (16 women and 4 men) were involved to research, who were in Republican Specialized Scientific-Practical Medical Center of Surgery in 2016–2018. All patients had obesity III for WOG, 2011. Comorbity was evaluated by Nedogoda recommendations (2016), metabolic status by Cardiometabolic Disease Staging (Guo, 2015) scale.
Results and Discussion. It was established, that obesity III (BMI (49.4±2.5) kg / m2) is associated with dyslipidemia / hypertriglyceridemia in 85 % of cases; diabetes mellitus-2 / glucose intolerance – in 50 %, arterial hypertension in – 45 %; non-alcoholic fatty liver disease (NAFLD) – in 35 % of cases. LSG and IBI allow to achieve weight loss by 21.1 % and 16.2 % vs initial weight; both were similar effective (p > 0.05). It caused decreasing of comorbidity: glucose intolerance is reduced by 2 times, arterial hypertension – by 3 times; dyslipidemia – by 1.9 times; NAFLD – by 1.8 times in 6 months after intervention. LSG and IBI allow to improve parameters by scale Cardiometabolic Disease Staging, having achieved zero cardiometabolic risk in 35 % of patients, and at other patients – transition to easier stage. Weight loss and reduction of comorbidity after LSG and IBI are combined with decrease of proinflammatory cytokines – IL-6, TNF-a and C-reactive protein.
References
Mazo, G.E., & Kibitov, A.O. (2018). Mekhanizmy formirovaniya komorbidnosti depressii i ozhireniya [Mechanisms of forming of comorbidity depression and obesity]. Obozreniye psikhiatrii i meditsinskoy psikhologii imeni V.M. Bekhtereva – V.M. Bechterew Survey of psychiatry and medical psychology, 1, 65-78 [in Russian].
Nedogoda, S.V., Vortkin, A.L., Naumov, A.V., Barykina, I.N., & Salasyuk, A.S. (2016). Ozhireniye i komorbidnaya patologiya v praktike poliklinicheskogo vracha [Obesity and comorbid pathology in the practice of a polyclinic physician]. Ambulatornyy priyem – Outpatient consultation, 4 (1), 4-14 [in Russian].
Nedogoda, S.V., Vortkin, A.L., Naumov, A.V., Barykina, I.N., & Salasyuk, A.S. (2016). Ozhireniye i komorbidnaya patologiya v praktike poliklinicheskogo vracha (opredeleniye, diagnostika; nemedikamentoznoye lecheniye; lecheniye ozhireniya i komorbidnoy patologii) [Obesity and comorbid pathology in the practice of a polyclinic physician (definition, diagnosis, non-drug treatment, treatment of obesity and comorbid pathology)]. Ambulatornyy priyem – Outpatient consultation, 2 (5), 16-21 [in Russian].
Shelest, B.O. (2017). Vzaimosvyaz narusheniy gormonov zhirovoy tkani i interleykinov u bolnykh arterialnoy gipertenziyey s komorbidnoy patologiyey [Interrelation of disorders of fatty tissue hormones and interleukins in patients with arterial hypertension with comorbid pathology]. Zaporozhskiy meditsinskiy zhurnal – Zaporozhye Medical Journal, 19 (2), 135-138 [in Russian].
Khashimov, Sh.H., Mahmudov, U.M., Djumaniyazov, Zh.A., Khon, K.M., Sadykov, N.S., Kabulov, T.M., & Tashkenbaev, F.R. (2018). Rezultaty primeneniya vnutrizheludochnykh ballonov v lechenii alimentarnogo ozhireniya. Pervyy opyt v Uzbekistane [Results of the use of intragastric balloons in the treatment of alimentary obesity. The first experience in Uzbekistan]. Khirurgiya Uzbekistana – Surgery of Uzbekistan, 1, 36-42 [in Russian].
Aminian, A., Brethauer, S.A., Andalib, A., Punchai, S., Mackey, J., Rodriguez, J., ... & Schauer, P.R. (2016). Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Annals of surgery, 264 (4), 674-681.
Blüher, M., Rudich, A., Klöting, N., Golan, R., Henkin, Y., Rubin, E., ... & Thiery, J. (2011). Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes care, 2, 342-349.
Choi, Y.J., Shin, H.S., Choi, H.S., Park, J.W., Jo, I., Oh, E.S., ... & Kang, D.H. (2014). Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Laboratory investigation, 94 (10), 1114-1125.
Guo, F., & Garvey, W.T. (2015). Development of a weighted Cardiometabolic Disease Staging (CMDS) system for the prediction of future diabetes. The Journal of Clinical Endocrinology & Metabolism, 100 (10), 3871-3877.
Hohensinner, P.J., Kaun, C., Ebenbauer, B., Hackl, M., Demyanets, S., Richter, D., ... & Rega-Kaun, G. (2018). Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients. Obesity surgery, 1-7.
Jensen, T., Abdelmalek, M.F., Sullivan, S., Nadeau, K.J., Green, M., Roncal, C., ... & Tolan, D.R. (2018). Fructose and sugar: a major mediator of nonalcoholic fatty liver disease. Journal of Hepatology, 268, 1063-1075.
Khukhlina, O.S., Antoniv, A.A., Mandryk, O.Y., Hryniuk, O.Y., Kovalenko, S.V., Drozd, V.Y., & Kotsiubiichuk, Z.I. (1960). Clinical and pathogenetic features of nonalcoholic steatohepatitis for comorbidity with bronchial asthma on the background of obesity. Wiadomosci lekarskie, Warsaw, Poland, 71 (2 pt 1), 376-379.
Kim, M.S., Krawczyk, S.A., Doridot, L., Fowler, A.J., Wang, J.X., Trauger, S. A., ... & Kim, J.K. (2016). ChREBP regulates fructose-induced glucose production independently of insulin signaling. The Journal of clinical investigation, 126 (11), 4372-4386.
Korean Endocrine Society, Korean Society for the Study of Obesity. (2010). Management of obesity, 2010 recommendation. Endocrinol Metab, 25 (4), 301-304.
Lauridsen, B.K., Stender, S., Kristensen, T.S., Kofoed, K.F., Køber, L., Nordestgaard, B.G., & Tybjærg-Hansen, A. (2017). Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals. European Heart Journal, 39 (5), 385-393.
Liu, Z., Que, S., Zhou, L., & Zheng, S. (2015). Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies. Scientific Reports, 5, 14325.
Peterli, R., Wölnerhanssen, B.K., Peters, T., Vetter, D., Kröll, D., Borbély, Y., ... & Nett, P. (2018). Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA, 319 (3), 255-265.
Petta, S., Camma, C., Cabibi, D., Di Marco, V. & Craxì, A. (2011). Hyperuricemia is associated with histological liver damage in patients with nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics, 34 (7), 757-766.
Salminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., ... & Victorzon, M. (2018). Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA, 319 (3), 241-254.
Song, H.J., Lee, E.K. & Kwon, J.W. (2016). Gender differences in the impact of obesity on health-related quality of life. Asia Pacific Journal of Public Health, 28 (2), 146-156.
Song, H.J., Hwang, J., Pi, S., Ahn, S., Heo, Y., Park, S., & Kwon, J.W. (2018). The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013. PloS One, 13 (5), e0197057.
Switzer, N. J., Prasad, S., Debru, E., Church, N., Mitchell, P., & Gill, R. S. (2016). Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review of long-term outcomes. Obesity surgery, 26 (7), 1616-1621.
VanWagner, L. B. (2018). New insights into NAFLD and subclinical coronary atherosclerosis. Journal of Hepatology, 68 (5), 890-892.
Yang, F., Wang, G., Wang, Z., Sun, M., Cao, M., Zhu, Z., ... & Yang, T. (2014). Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness. PloS One, 9 (8), e104365.
Yska, J.P., Van Roon, E.N., De Boer, A., Leufkens, H.G., Wilffert, B., De Heide, L.J., ... & Lalmohamed, A. (2015). Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery: a population-based cohort study in the United Kingdom. JAMA Surgery, 150 (12), 1126-1133.
Downloads
Published
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
